As estrogen protects against various cardiovascular diseases, including DCM, by influencing cardiac metabolism, gene expression, and structural integrity [14, 28–30, 73, 74], we propose that A1BG acts downstream or in parallel to estrogen signaling. Here, A1BG is linked to familial dilated cardiomyopathy.